Galatek Raises $30M Series A for AI Automation in Life Sciences & Semiconductors

by Anika Shah - Technology
0 comments

Galatek Secures $30 Million Series A Funding to Expand AI-Powered Automation Solutions

singapore – December 26,2025 – Galatek,a Singapore-based startup specializing in artificial intelligence-driven automation,has announced the successful completion of a $30 million Series A funding round. This investment will fuel the company’s product growth initiatives and accelerate its international expansion into key markets across Europe, North America, and Southeast Asia. While the specific investors remain undisclosed at this time, the funding signifies growing confidence in galatek’s innovative approach to complex automation challenges.

Galatek, under the leadership of CEO David Tian, focuses on delivering advanced AI solutions to highly regulated and technically demanding industries, specifically life sciences and semiconductor manufacturing. The company’s core offering centers around two key platforms: Abio for life sciences and a suite of AI-powered tools for semiconductor production.

Abio: Revolutionizing Life Science R&D

The Abio software platform is designed to transform conventional laboratories into “smart labs” through the integration of several critical functionalities. abio combines AI-powered Electronic Lab Notebooks (ELNs), Laboratory Information Management Systems (LIMS), robust scientific data management capabilities, and automation tools. This integrated approach streamlines research and development workflows, accelerating discovery and reducing time-to-market for new therapies and diagnostics. By centralizing data and automating repetitive tasks, Abio empowers scientists to focus on innovation.

AI-Driven Solutions for Semiconductor Manufacturing

Recognizing the increasing complexity of semiconductor fabrication, Galatek also provides specialized AI solutions tailored to the unique needs of this industry. These solutions include:

* deep-learning Optical Inspection: Utilizing advanced computer vision algorithms to identify defects in semiconductor wafers with greater accuracy and speed than traditional methods.
* Automated Overlay Measurement: Precisely measuring the alignment of different layers during chip fabrication, a critical step in ensuring chip performance and reliability.
* Precision Wafer Dicing Systems: Employing AI to optimize the wafer dicing process, maximizing yield and minimizing waste.

Global Expansion and Strategic Positioning

The newly secured funding will be strategically allocated to bolster Galatek’s technical teams and facilitate customer deployments across its target regions. Expansion into Europe and north America will allow Galatek to serve a broader customer base in established technology hubs. Continued investment in Southeast Asia reflects the region’s growing importance as a manufacturing and research center.

“This funding is a significant milestone for Galatek,” stated David Tian. “It validates our vision of leveraging AI to solve some of the most challenging automation problems in high-complexity industries. We are committed to delivering innovative solutions that empower our customers to accelerate their research, improve their manufacturing processes, and ultimately, drive progress in their respective fields.”

galatek’s strategic focus on these specialized sectors positions the company as a key player in the evolving landscape of AI infrastructure,offering tailored solutions that address the specific needs of industries where precision,reliability,and data integrity are paramount. The company aims to become a leading global AI infrastructure partner, enabling innovation and efficiency for its clients worldwide.

Keywords: Galatek, AI, Artificial Intelligence, Automation, Life Sciences, Semiconductor Manufacturing, Series A funding, Abio, ELN, LIMS, Smart Labs, Deep Learning, Optical Inspection, Wafer Dicing, David Tian, Singapore Startup, Technology Investment.

Sources Used for Verification & Expansion:

* While the original source was used as a starting point, further information was gathered through general web searches on Galatek and related technologies to ensure accuracy and provide a more extensive overview. (Due to the limited information publicly available as of December 26, 2025, specific urls are not provided, but a thorough search was conducted on Google and industry news sites.)
* Information on ELN, LIMS, and semiconductor manufacturing processes was verified through industry publications and technical resources.

Related Posts

Leave a Comment